who we are
Dr Dan Barker
Professor Krasimir Vasilev
Dr Dan Barker
Dr Dan Barker has held senior R&D and commercial roles in the world’s largest multinational orthopaedic companies. His most recent role was Chief Technology Officer at Global Orthopaedic Technology, which was acquired in 2018 by the multinational Corin Orthopaedics. Prior to this, Dan was the Asia Pacific Director of R&D for Zimmer Biom
Dr Dan Barker has held senior R&D and commercial roles in the world’s largest multinational orthopaedic companies. His most recent role was Chief Technology Officer at Global Orthopaedic Technology, which was acquired in 2018 by the multinational Corin Orthopaedics. Prior to this, Dan was the Asia Pacific Director of R&D for Zimmer Biomet, the world’s largest pure play orthopaedic company. Dan has successfully brought orthopaedic products and technologies to market in a variety of countries. Dan holds a PhD from Flinders University and has particular expertise with commercial-academic partnerships to realise product and technology outcomes. Dan has led the project management of multi-millions dollar commercialisation and development projects and managed teams across different countries and disciplines, bringing diverse people and skillsets together to achieve commercial outcomes.
Stuart Baxter
Professor Krasimir Vasilev
Dr Dan Barker
Stuart Baxter joined Riverside in 1997 and is a Founding Partner of Riverside Asia-Pacific Fund. He has led investment teams across three of Riverside’s fund families. He launched Riverside Europe Fund and supervised all negotiations, legal due diligence and post-acquisition board work. Prior to joining Riverside, Mr. Baxter was Direc
Stuart Baxter joined Riverside in 1997 and is a Founding Partner of Riverside Asia-Pacific Fund. He has led investment teams across three of Riverside’s fund families. He launched Riverside Europe Fund and supervised all negotiations, legal due diligence and post-acquisition board work. Prior to joining Riverside, Mr. Baxter was Director of Crimson Capital’s Czech Restructuring and Privatization Group for two years. Prior to that, Stuart was President of AI International Corporation, the U.S.-based holding company for a high-net-worth Kuwaiti family. He spent 12 years at AI International Corporation, managing various operating businesses, venture capital and real estate portfolios and executing over 30 acquisitions. He began his career in investment banking as an analyst at Credit Suisse First Boston. He holds a BA in economics from Stanford University.
Professor Krasimir Vasilev
Professor Krasimir Vasilev
Professor Krasimir Vasilev
Professor Krasimir Vasilev is a key academic collaborator at the University of South Australia, and a world leader in nanosurfaces for medical devices. Krasimir is furthermore an internationally leading expert in biomedical device engineering having published more that 200 research articles, reviews, books and book chapters. He has held
Professor Krasimir Vasilev is a key academic collaborator at the University of South Australia, and a world leader in nanosurfaces for medical devices. Krasimir is furthermore an internationally leading expert in biomedical device engineering having published more that 200 research articles, reviews, books and book chapters. He has held several prestigious Research Fellowships such as from the ARC, NHMRC and the Humboldt Foundation, and has received a number of awards including the John A Brodie Medal from Engineers Australia. Professor Vasilev has been awarded competitive research funding for more than $20M and has led commercialization and translational projects such as on bladder cancer diagnostics (with SMR Automotive Pty Ltd) and antibacterial orthopaedic implants.